Skip to main content
Top

Current Treatment Options in Oncology

Issue 6/2023

Content (9 Articles)

Current Management Options for Dyspnea in Cancer Patients

Masanori Mori, Satoru Miwa, Tomoo Ikari, Jun Kako, Takaaki Hasegawa, Ryo Matsunuma, Kozue Suzuki, Yoshinobu Matsuda, Hiroaki Watanabe, Tatsuya Morita, Takashi Yamaguchi

Thrombosis in Acute Myeloid Leukemia: Pathogenesis, Risk Factors and Therapeutic Challenges

Matteo Olivi, Federica Di Biase, Giuseppe Lanzarone, Giulia Arrigo, Federica Martella, Vincenzo Apolito, Carolina Secreto, Roberto Freilone, Benedetto Bruno, Ernesta Audisio, Dario Ferrero, Eloise Beggiato, Marco Cerrano

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine